Quick Answer
Camp4 Therapeutics Corp reported Operating Income of -$52.55 million for fiscal year 2025.
Camp4 Therapeutics Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$52.55M | +1.0% |
| 2024 | -$53.09M | -2.3% |
| 2023 | -$51.88M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.65M | -1.0% | -4.8% |
| June 30, 2025 | -$13.03M | -2.9% | +0.5% |
| March 31, 2025 | -$13.10M | -1.7% | +3.1% |
| September 30, 2024 | -$13.52M | -9.5% | -6.7% |
| June 30, 2024 | -$12.66M | — | +1.7% |
| March 31, 2024 | -$12.88M | — | -4.4% |
| September 30, 2023 | -$12.34M | — | — |
- Camp4 Therapeutics Corp showed an increase of +1.0% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Camp4 Therapeutics Corp’s operating income has declined by 1.3% (from -$51.88 million to -$52.55 million).
- The most recent figure is from Camp4 Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: